Tenaya Therapeutics Inc (TNYA) Live Share Price, Invest From India

Tenaya Therapeutics Inc Stock Performance

as on April 11, 2026 at 6:59 am IST

Day's Low
Day's High
$0.68
Day's Price Range
$0.74
$0.70
2.86%
Downside
5.71%
Upside
52 Week's Low
52 Week's High
$0.36
52-Week Price Range
$2.35
$0.70
48.57%
Downside
235.71%
Upside

Tenaya Therapeutics Inc share price movements today

Previous Close: $0.74
Open: $0.74
Volume: 4.9M
Day's Low - High: $0.68 - $0.74
52 Week Low - High: $0.36 - $2.35

Tenaya Therapeutics Inc Historical Returns

1 Month Return: -19.65 %
3 Month Return: -9.76 %
1 Year Return: + 39.99 %
3 Year Return: -77.15 %
5 Year Return: 0 %

Tenaya Therapeutics Inc Stock Fundamentals & Key Indicators

Check Tenaya Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$160.6M

EPS (TTM)

-0.4288

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-84.9M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-83.84%

Tenaya Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Tenaya Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Tenaya Therapeutics Inc	BUY	$160.6M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$42.6B	133.02%	140.91	8.45%
Vertex Pharmaceuticals Incorporated	BUY	$113.6B	104.49%	29.16	32.94%
Beone Medicines Ltd	NA	$36.0B	NA	126.38	5.37%
Regeneron Pharmaceuticals, Inc.	BUY	$81.2B	57.6%	18.52	31.41%

Stock Returns calculator for Tenaya Therapeutics Inc Stock including INR - Dollar returns

The Tenaya Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Tenaya Therapeutics Inc investment value today

Current value as on today

₹1,54,478

Returns

₹54,478

(+54.48%)

Returns from Tenaya Therapeutics Inc Stock

₹42,857 (+42.86%)

Dollar Impact

₹11,621 (+11.62%)

Analyst Recommendation on Tenaya Therapeutics Inc Stock

Based on 14 analysts

BUY

92.86%

Buy

7.14%

Hold

0.00%

Sell

Based on 14 analysts, 92.86% of analysts recommend a 'BUY' rating for Tenaya Therapeutics Inc. Average target price of $9

Tenaya Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Tenaya Therapeutics Inc.

What analysts predicted

92.22%UPSIDE

Target Price

Current Price

$0.7

Analyzed by

14 Analysts

Target

$9.00

Tenaya Therapeutics Inc target price $9, a slight upside of 92.22% compared to current price of $0.7. According to 14 analysts rating.

Tenaya Therapeutics Inc Stock’s Investor Sentiment and Interest

Investment in Tenaya Therapeutics Inc Shares on INDmoney has dropped by -30.00% over the past 30 days, indicating reduced transactional activity.

Time period: March 14, 2026 to April 13, 2026

Change:-30.00% versus previous 30 day period

Search interest for Tenaya Therapeutics Inc Stock has increased by 53% in the last 30 days, reflecting an upward trend in search activity.

Time period: March 14, 2026 to April 13, 2026

Change:53% versus previous 30 day period

Tenaya Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	17	-	-	-	-	-	-	-	-
Gross Profit	-2	-2	-2	-2	-	-	-	-2	-1	3
Operating Income	-30	-31	-33	-30	-26	-24	-27	-24	-20	-20
EBITDA	-26	-26	-30	-27	-24	-22	-24	-21	-18	-18
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	2	2	2	2	2	2	2	2	1	1
Income Before Tax	-29	-29	-32	-29	-25	-23	-26	-23	-20	-20
Income Tax Expense	3	2	2	-	-	-	-	-	-	-
Net Income	-29	-29	-32	-29	-25	-23	-26	-23	-20	-20
Net Profit Margin	0.00%	-169.47%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Tenaya Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	-
Gross Profit	-1	-2	-4	-8	-8	-8	-8
Operating Income	-27	-38	-72	-125	-131	-115	-93
EBITDA	-25	-35	-69	-119	-115	-102	-84
Interest Expense	-	-	72	0	-	-	-
Depreciation	1	2	2	6	8	8	8
Income Before Tax	-26	-38	-72	-123	-124	-111	-90
Income Tax Expense	0	0	-3	0	8	-111	-
Net Income	-25	-38	-69	-123	-124	-111	-90
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Tenaya Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-29	-32	-29	-25	-23	-26	-23	-20	-20
Operating Cash Flow	-21	-28	-23	-19	-18	-23	-15	-15	-13
Investing Cash Flow	-14	-4	21	-30	14	22	24	8	0
Financing Cash Flow	0	46	0	0	0	50	0	0	58
Change in Cash	-36	13	-1	-49	-3	49	8	-6	44

Tenaya Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-38	-72	-123	-124	-111	-90
Operating Cash Flow	-35	-60	-104	-102	-90	-68
Investing Cash Flow	-7	-238	83	48	1	56
Financing Cash Flow	147	208	77	4	47	108
Change in Cash	104	-90	56	-49	-41	96

Global Institutional Holdings in Tenaya Therapeutics Inc

Funds	Holdings
Empery Asset Management, LP	2.5%
Euclidean Capital LLC	0.47%
Millennium Management LLC	2.13%
Citadel Advisors Llc	1.94%
ADAR1 Capital Management LLC	0.69%

See all

Insights on Tenaya Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, TNYA has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 58.8% return, outperforming this stock by 134.7%
NEGATIVE IMPACT
Price Dip
In the last 1 month, TNYA stock has moved down by -22.7%

About Tenaya Therapeutics Inc

tenaya therapeutics is a privately-held biopharmaceutical company backed by the column group. the company was founded in 2016 by world-leading scientists from the gladstone institute’s cardiovascular division and the university of texas southwestern medical center. tenaya is dedicated to addressing heart failure through multipronged efforts that target the fundamental cellular pathologies present in diseased cardiac muscle and that leverage cutting-edge research in cardiac development and regeneration. tenaya has a lead gene therapy program focused on in vivo reprogramming of cardiac fibroblasts to cardiomyocytes to regenerate heart tissue, and additional programs focused on cardiomyopathies.

Organisation	Tenaya Therapeutics Inc
Headquarters	171 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
CEO	Mr. Faraz Ali M.B.A.
E-voting on shares	Click here to vote

Key Management of Tenaya Therapeutics Inc

Name	Title
Mr. Faraz Ali M.B.A.	CEO, Interim Principal Financial Officer & Director
Dr. Whittemore G. Tingley M.D., PH.D.	Chief Medical Officer
Dr. Eric N. Olson Ph.D.	Scientific Founder & Member of Scientific Advisory Board
Mr. Tomohiro Higa M.B.A.	Senior Vice President of Finance & Interim Principal Accounting Officer
Dr. Deepak Srivastava M.D.	Scientific Founder, Chairman of Scientific Advisory Board & Director
Dr. Bruce R. Conklin M.D.	Scientific Founder
Dr. Saptarsi Haldar M.D.	Scientific Founder
Dr. Sheng Ding Ph.D.	Scientific Founder
Dr. Benoit G. Bruneau Ph.D.	Scientific Founder
Dr. Kee-Hong Kim Ph.D.	Chief Technology Officer

FAQs

What is Tenaya Therapeutics Inc share price today?

Tenaya Therapeutics Inc share price today is $0.7 as on April 11, 2026 at 1:29 am IST at the close of the market. Tenaya Therapeutics Inc share today touched a day high of $0.74 and a low of $0.68.

What is the 52 week high and 52 week low for Tenaya Therapeutics Inc share?

Tenaya Therapeutics Inc share touched a 52 week high of $2.35 on October 10, 2025 and a 52 week low of $0.36 on May 13, 2025. Tenaya Therapeutics Inc stock price today i.e. April 11, 2026 at 1:29 am IST is closed at $0.7,which is 70.21% down from its 52 week high and 94.44% up from its 52 week low.

What is Tenaya Therapeutics Inc's market capitalisation today?

Tenaya Therapeutics Inc market capitalisation is $0.00T as on April 11, 2026 at 1:29 am IST.

How to invest in Tenaya Therapeutics Inc Stock (TNYA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Tenaya Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Tenaya Therapeutics Inc Shares that will get you 2.1429 shares as per Tenaya Therapeutics Inc share price of $0.7 per share as on April 11, 2026 at 1:29 am IST.

What is the minimum amount required to buy Tenaya Therapeutics Inc Stock (TNYA) from India?

Indian investors can start investing in Tenaya Therapeutics Inc (TNYA) shares with as little as ₹93.048 or $1 (as of April 13, 2026 at 1:41 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹930.48 in Tenaya Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on April 13, 2026 at 1:41 am IST). Based on Tenaya Therapeutics Inc share’s latest price of $0.7 as on April 11, 2026 at 1:29 am IST, you will get 14.2857 shares of Tenaya Therapeutics Inc. Learn more about fractional shares .